Authors
Loading...
Comparative analysis reveals downregulation of α2δ1 in canine prostate cancer versus benign prostatic hyperplasia, suggesting its role as a potential biomarker.
Zacharski et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: